Mark J. Sartain

802 total citations
10 papers, 538 citations indexed

About

Mark J. Sartain is a scholar working on Molecular Biology, Epidemiology and Spectroscopy. According to data from OpenAlex, Mark J. Sartain has authored 10 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Epidemiology and 4 papers in Spectroscopy. Recurrent topics in Mark J. Sartain's work include Mass Spectrometry Techniques and Applications (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Tuberculosis Research and Epidemiology (3 papers). Mark J. Sartain is often cited by papers focused on Mass Spectrometry Techniques and Applications (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Tuberculosis Research and Epidemiology (3 papers). Mark J. Sartain collaborates with scholars based in United States, France and Czechia. Mark J. Sartain's co-authors include John T. Belisle, Robert L. Moritz, Christopher D. Rithner, Dean C. Crick, Donald L. Dick, Krishna K. Singh, Suman Laal, Richard A. Slayden, Alan Aderem and Stephen A. Ramsey and has published in prestigious journals such as The Journal of Experimental Medicine, Analytical Chemistry and Scientific Reports.

In The Last Decade

Mark J. Sartain

10 papers receiving 528 citations

Peers

Mark J. Sartain
Jason L. Larabee United States
Travis R. Ruch United States
Andrea Maggioni Australia
Yu‐Shan Cheng United States
David L. Evers United States
Alison R. Erickson United States
Annette S. Uss United States
Jeff D. Moore United States
Mark J. Sartain
Citations per year, relative to Mark J. Sartain Mark J. Sartain (= 1×) peers Xiaoling Su

Countries citing papers authored by Mark J. Sartain

Since Specialization
Citations

This map shows the geographic impact of Mark J. Sartain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Sartain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Sartain more than expected).

Fields of papers citing papers by Mark J. Sartain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Sartain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Sartain. The network helps show where Mark J. Sartain may publish in the future.

Co-authorship network of co-authors of Mark J. Sartain

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Sartain. A scholar is included among the top collaborators of Mark J. Sartain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Sartain. Mark J. Sartain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Liu, Yi, et al.. (2023). Ion mobility mass spectrometry for the study of mycobacterial mycolic acids. Scientific Reports. 13(1). 10390–10390. 3 indexed citations
2.
Apffel, Alex, Limian Zhao, & Mark J. Sartain. (2021). A Novel Solid Phase Extraction Sample Preparation Method for Lipidomic Analysis of Human Plasma Using Liquid Chromatography/Mass Spectrometry. Metabolites. 11(5). 294–294. 13 indexed citations
4.
Zhang, Xing, Kimberly Kew, Richard Reisdorph, et al.. (2017). Performance of a High-Pressure Liquid Chromatography-Ion Mobility-Mass Spectrometry System for Metabolic Profiling. Analytical Chemistry. 89(12). 6384–6391. 36 indexed citations
5.
Lindner, Scott E., Mark J. Sartain, Anke Harupa, et al.. (2013). Enzymes involved in plastid‐targeted phosphatidic acid synthesis are essential for Plasmodium yoelii liver‐stage development. Molecular Microbiology. 91(4). 679–693. 38 indexed citations
6.
Brusniak, Mi‐Youn, Caroline S. Chu, Ulrike Kusebauch, et al.. (2012). An assessment of current bioinformatic solutions for analyzing LCMS data acquired by selected reaction monitoring technology. PROTEOMICS. 12(8). 1176–1184. 17 indexed citations
7.
Gold, Elizabeth S., Stephen A. Ramsey, Mark J. Sartain, et al.. (2012). ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol–induced lipid body formation. The Journal of Experimental Medicine. 209(4). 807–817. 117 indexed citations
8.
Sartain, Mark J., Donald L. Dick, Christopher D. Rithner, Dean C. Crick, & John T. Belisle. (2011). Lipidomic analyses of Mycobacterium tuberculosis based on accurate mass measurements and the novel “Mtb LipidDB”. Journal of Lipid Research. 52(5). 861–872. 108 indexed citations
9.
Sartain, Mark J. & John T. Belisle. (2008). N-Terminal clustering of the O-glycosylation sites in the Mycobacterium tuberculosis lipoprotein SodC. Glycobiology. 19(1). 38–51. 48 indexed citations
10.
Sartain, Mark J., Richard A. Slayden, Krishna K. Singh, Suman Laal, & John T. Belisle. (2006). Disease State Differentiation and Identification of Tuberculosis Biomarkers via Native Antigen Array Profiling. Molecular & Cellular Proteomics. 5(11). 2102–2113. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026